Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study

被引:20
作者
Abe, Masanori [1 ,2 ]
Masakane, Ikuto [1 ,3 ]
Wada, Atsushi [1 ,4 ]
Nakai, Shigeru [1 ,5 ]
Nitta, Kosaku [1 ,6 ]
Nakamoto, Hidetomo [1 ,7 ]
机构
[1] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan
[2] Nihon Univ, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Sch Med, Tokyo, Japan
[3] Yabuki Hosp, Yamagata, Japan
[4] Kitasaito Hosp, Dept Nephrol, Asahikawa, Hokkaido, Japan
[5] Fujita Hlth Univ, Dept Clin Engn, Toyoake, Aichi, Japan
[6] Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan
[7] Saitama Med Univ, Dept Gen Internal Med, Saitama, Japan
关键词
beta(2)-microglobulin; hemodialysis; high-flux dialyzer; low-flux dialyzer; super high-flux dialyzer; THERAPY CLINICAL GUIDELINE; REGULAR DIALYSIS TREATMENT; JAPANESE SOCIETY; HEMODIAFILTRATION; OUTCOMES;
D O I
10.1093/ckj/sfab177
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction In Japan, dialyzers are classified based on beta(2)-microglobulin clearance. Type I dialyzers are classified as low-flux dialyzers (<10 mL/min clearance), type II and III as high-flux dialyzers (>= 10 to <30 mL/min and >= 30 to <50 mL/min clearance, respectively), and type IV and V as super high-flux dialyzers (>= 50 to <70 mL/min and >= 70 mL/min clearance, respectively). Super high-flux dialyzers are commonly used, but their superiority over low-flux dialyzers is controversial. Methods In this nationwide prospective cohort study, we analyzed Japanese Society for Dialysis Therapy Renal Data Registry data collected at the end of 2008 and 2011. We enrolled 242,467 patients on maintenance hemodialysis and divided them into five groups by dialyzer type. We assessed the associations of each dialyzer type with 3-year all-cause mortality using Cox proportional hazards models and performed propensity score matching analysis, adjusting for potential confounders. Results By the end of 2011, 53,172 (21.9%) prevalent dialysis patients had died. Mortality significantly decreased according to dialyzer type. Hazard ratios (HRs) were significantly higher for type I, II and III compared with type IV (reference) after adjustment for basic factors and further adjustment for dialysis-related factors. HR was significantly higher for type I, but significantly lower for type V, after further adjustment for nutrition- and inflammation-related factors. These significant findings were also evident after propensity score matching. Conclusions Hemodialysis using super high-flux dialyzers might reduce mortality. Randomized controlled trials are warranted to clarify whether these type V dialyzers can improve prognosis.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 42 条
  • [1] Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry
    Abe, Masanori
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. PLOS ONE, 2017, 12 (09):
  • [2] High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry
    Abe, Masanori
    Hamano, Takayuki
    Wada, Atsushi
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (01) : 82 - 92
  • [3] Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?
    Abe, Masanori
    Hamano, Takayuki
    Hoshino, Junichi
    Wada, Atsushi
    Inaba, Masaaki
    Nakai, Shigeru
    Masakane, Ikuto
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 130 : 211 - 220
  • [4] Adsorption Dialysis: From Physical Principles to Clinical Applications
    Aucella, Filippo
    Gesuete, Antonio
    Vigilante, Mimmo
    Prencipe, Michele
    [J]. BLOOD PURIFICATION, 2013, 35 : 42 - 47
  • [5] Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial
    Belmouaz, Mohamed
    Bauwens, Marc
    Hauet, Thierry
    Bossard, Valentin
    Jamet, Pierre
    Joly, Florent
    Chikhi, Elise
    Joffrion, Sandrine
    Gand, Elise
    Bridoux, Frank
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (02) : 328 - 335
  • [6] Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
    Belmouaz, Mohamed
    Diolez, Jeremy
    Bauwens, Marc
    Duthe, Fabien
    Ecotiere, Laure
    Desport, Estelle
    Bridoux, Frank
    [J]. CLINICAL NEPHROLOGY, 2018, 89 (01) : 50 - 56
  • [7] Effects of high-flux Hemodialysis on clinical outcomes: Results of the HEMO study
    Cheung, AK
    Levin, NW
    Greene, T
    Agodoa, L
    Bailey, J
    Beck, G
    Clark, W
    Levey, AS
    Leypoldt, JK
    Ornt, DB
    Rocco, MV
    Schulman, G
    Schwab, S
    Teehan, B
    Eknoyan, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12): : 3251 - 3263
  • [8] Serum β-2 microglobulin levels predict mortality in dialysis patients:: Results of the HEMO study
    Cheung, Alfred K.
    Rocco, Michael V.
    Yan, Guofen
    Leypoldt, John K.
    Levin, Nathan W.
    Greene, Tom
    Agodoa, Lawrence
    Bailey, James
    Beck, Gerald J.
    Clark, William
    Levey, Andrew S.
    Ornt, Daniel B.
    Schulman, Gerald
    Schwab, Steven
    Teehan, Brendan
    Eknoyan, Garabed
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02): : 546 - 555
  • [9] Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015
  • [10] High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration
    Donadio, Carlo
    Kanaki, Angeliki
    Sami, Nadia
    Tognotti, Danika
    [J]. BLOOD PURIFICATION, 2017, 44 (02) : 129 - 139